Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 538 (7624), 193-200

The Evolution of Ebola Virus: Insights From the 2013-2016 Epidemic

Affiliations
Review

The Evolution of Ebola Virus: Insights From the 2013-2016 Epidemic

Edward C Holmes et al. Nature.

Abstract

The 2013-2016 epidemic of Ebola virus disease in West Africa was of unprecedented magnitude and changed our perspective on this lethal but sporadically emerging virus. This outbreak also marked the beginning of large-scale real-time molecular epidemiology. Here, we show how evolutionary analyses of Ebola virus genome sequences provided key insights into virus origins, evolution and spread during the epidemic. We provide basic scientists, epidemiologists, medical practitioners and other outbreak responders with an enhanced understanding of the utility and limitations of pathogen genomic sequencing. This will be crucially important in our attempts to track and control future infectious disease outbreaks.

Figures

Figure 1
Figure 1. Evolution of EBOV during the 2013–2106 outbreak showing the extent and location of virus sampling
(a) Sampling during the 2013–2016 EVD epidemic. Sequencing efforts closely match confirmed and suspected case numbers in each administrative division of Guinea (green), Liberia (red) and Sierra Leone (blue) (Spearman correlation coefficient = 0.91). (b) Map of the three countries most affected by EVD during the 2013–2016 EVD epidemic. Administrative divisions in Guinea, Liberia and Sierra Leone are shown in green, red and blue, respectively, and colored according to the cumulative numbers of confirmed and suspected cases throughout the epidemic. Hatched areas indicate divisions that never reported any cases. The boundary data for the maps is from GADM (http://www.gadm.org). (c) Temporal phylogeny of all publicly available EBOV genomes estimated using BEAST. Three lineages identified in previous studies,, are marked with colored backgrounds. The sequence alignment was partitioned into 4 categories: codon positions 1, 2 and 3, and non-coding intergenic regions. Changes in each of the 4 partitions were modelled according to the HKY+Γ4 nucleotide substitution model with relative rates between partitions. Tip dates were used to calibrate a relaxed molecular clock with rates drawn from a lognormal distribution with an uninformative prior placed on the mean of the distribution. A flexible ‘skygrid’ tree prior was used to allow for changes in effective population sizes over time. Each tip is colored according to the country where the patient was most likely infected: green for Guinea, red for Liberia and blue for Sierra Leone. All panels are current as of April 19th, 2016.
Figure 2
Figure 2. Evolutionary rates of EBOV compared to those of other RNA viruses
(a) Estimates of evolutionary rate in diverse RNA viruses. Green points at the top indicate the mean evolutionary rates estimated for EBOV during the 2013–2016 EVD epidemic from different studies, with dashed lines showing the 95% credible intervals derived from BEAST analyses. Points at the bottom represent equivalent estimates (without uncertainty intervals) published previously for negative-sense single-strand RNA viruses (red), positive-sense single-strand RNA viruses (blue) and double-strand RNA viruses (purple). Points colored the same shade belong to the same family. Evolutionary rate estimates for EBOV Makona occupy a narrow distribution within the range of rates observed in RNA viruses as a whole. (b) 95% credible intervals for the distribution of evolutionary rates for EBOV from the 2013–2016 EVD epidemic published previously. *An erratum revised the mean evolutionary rate estimate for Ref. to 1.32 × 10−3 [95% credible intervals: 0.89, 1.75 × 10−3] subs/site/year.
Figure 3
Figure 3. Examples of violations of the Ebola virus molecular clock
(a) Root-to-tip regression of genetic distances against time (month and year) of sampling for 105 representative EBOV variant sequences collected between 1976 and 2016 based on a maximum likelihood tree. (b) Equivalent root-to-tip regression of publicly available sequences from the 2013–2016 EVD epidemic utilizing data on the day of sampling, and the maximum likelihood tree on which the estimates were made. RAxML (panel A) and PhyML (panel B) were used to find the maximum likelihood phylogenies under an HKY+Γ4 substitution model which was rooted via least squares regression in TempEst. Substitutions accumulate linearly with time, with some variation. Sequences recovered from transmission events that occurred as a result of persistent EBOV infection often exhibit temporal anomalies. In this scenario, EBOV may accumulate substitutions at a lower rate during persistence in individuals compared to regular person-to-person transmission. Larger red points indicate sequences of EBOV sampled from EVD survivor-associated transmission chains,.
Figure
Figure. Different measures of genome sequence change
Mutations accumulate with time. This phenomenon is at the core of molecular clocks, a class of methods that aim to convert molecular phylogenies with branch lengths given in expected substitutions per site into plausible temporal phylogenies where branch lengths are given in time units and the trees themselves are embedded in time. By making use of sequences sampled at different times, such methods can estimate the evolutionary rate that provides the conversion from genetic distance into time. As phylogenetic methods have become ever more powerful and easily accessible, confusion has resulted from the frequent and interchangeable use of the terms mutation rate and substitution rate to signify the ‘molecular clock’ rate. Mutation and substitution rates, however, sit on the opposite ends of the evolutionary rate continuum and neither is the appropriate term for the molecular clock rate derived from densely sequenced epidemics.

Similar articles

  • Getting to the root of epidemic spread with phylodynamic analysis of genomic data.
    du Plessis L, Stadler T. du Plessis L, et al. Trends Microbiol. 2015 Jul;23(7):383-6. doi: 10.1016/j.tim.2015.04.007. Trends Microbiol. 2015. PMID: 26139467
  • Identifying the pattern of molecular evolution for Zaire ebolavirus in the 2014 outbreak in West Africa.
    Liu SQ, Deng CL, Yuan ZM, Rayner S, Zhang B. Liu SQ, et al. Infect Genet Evol. 2015 Jun;32:51-9. doi: 10.1016/j.meegid.2015.02.024. Epub 2015 Mar 4. Infect Genet Evol. 2015. PMID: 25745889
  • Real-time, portable genome sequencing for Ebola surveillance.
    Quick J, Loman NJ, Duraffour S, Simpson JT, Severi E, Cowley L, Bore JA, Koundouno R, Dudas G, Mikhail A, Ouédraogo N, Afrough B, Bah A, Baum JH, Becker-Ziaja B, Boettcher JP, Cabeza-Cabrerizo M, Camino-Sanchez A, Carter LL, Doerrbecker J, Enkirch T, Dorival IGG, Hetzelt N, Hinzmann J, Holm T, Kafetzopoulou LE, Koropogui M, Kosgey A, Kuisma E, Logue CH, Mazzarelli A, Meisel S, Mertens M, Michel J, Ngabo D, Nitzsche K, Pallash E, Patrono LV, Portmann J, Repits JG, Rickett NY, Sachse A, Singethan K, Vitoriano I, Yemanaberhan RL, Zekeng EG, Trina R, Bello A, Sall AA, Faye O, Faye O, Magassouba N, Williams CV, Amburgey V, Winona L, Davis E, Gerlach J, Washington F, Monteil V, Jourdain M, Bererd M, Camara A, Somlare H, Camara A, Gerard M, Bado G, Baillet B, Delaune D, Nebie KY, Diarra A, Savane Y, Pallawo RB, Gutierrez GJ, Milhano N, Roger I, Williams CJ, Yattara F, Lewandowski K, Taylor J, Rachwal P, Turner D, Pollakis G, Hiscox JA, Matthews DA, O'Shea MK, Johnston AM, Wilson D, Hutley E, Smit E, Di Caro A, Woelfel R, Stoecker K, Fleischmann E, Gabriel M, Weller SA, Koivogui L, Diallo B, Keita S, Rambaut A, Formenty P, Gunther S, Carroll MW. Quick J, et al. Nature. 2016 Feb 11;530(7589):228-232. doi: 10.1038/nature16996. Epub 2016 Feb 3. Nature. 2016. PMID: 26840485 Free PMC article.
  • Computational analysis of Ebolavirus data: prospects, promises and challenges.
    Michaelis M, Rossman JS, Wass MN. Michaelis M, et al. Biochem Soc Trans. 2016 Aug 15;44(4):973-8. doi: 10.1042/BST20160074. Biochem Soc Trans. 2016. PMID: 27528741 Review.
  • Ebola virus disease: a highly fatal infectious disease reemerging in West Africa.
    To KK, Chan JF, Tsang AK, Cheng VC, Yuen KY. To KK, et al. Microbes Infect. 2015 Feb;17(2):84-97. doi: 10.1016/j.micinf.2014.11.007. Epub 2014 Nov 29. Microbes Infect. 2015. PMID: 25456100 Review.
See all similar articles

Cited by 59 articles

See all "Cited by" articles

Publication types

Feedback